NephroGenex was formed to develop targeted drugs against certain defined kidney diseases. By using cutting edge technology, the genes and gene products involved in kidney diseases will be mapped and will form the basis for selecting known or novel drug candidates for clinical evaluation in targeted patient populations.
+1 919 678 95 12
